Showing results (241-250 of 320) with videos related to

Sort By:
Pageof 32
Clinical Gerontologist|January 26, 2024
Feasibility and Acceptability of a Videoconferencing CBT Intervention for Anxiety in People with Parkinson's DiseaseAmy Roper, Deborah Brooks, Leander K Mitchell, et al.
The Journal of Arthroplasty|September 19, 2020
Improvement in Sleep Patterns After Hip and Knee Arthroplasty: A Prospective Study in 780 PatientsJan P Van Meirhaeghe, Lucy J Salmon, Michael D O'Sullivan, et al.
The Journal of Arthroplasty|February 8, 2024
Gluteal Tendinopathy Is Associated With Lower Patient-Reported Outcome Measures in Total Hip Arthroplasty With a Posterior Approach: A Prospective Cohort Study of 1,538 PatientsYoan Bourgeault-Gagnon, David Lin, Lucy J Salmon, et al.
Biomedical Optics Express|September 7, 2013
Real-time, continuous, fluorescence sensing in a freely-moving subject with an implanted hybrid VCSEL/CMOS biosensorThomas D O'Sullivan, Roxana T Heitz, Natesh Parashurama, et al.
Clinical Genetics|March 23, 2016
Phenotype-driven molecular autopsy for sudden cardiac deathF Cann, M Corbett, D O'Sullivan, et al.
ANZ Journal of Surgery|September 3, 2018
Inpatient rehabilitation did not positively affect 6-month patient-reported outcomes after hip or knee arthroplastyAdam G Hutchinson, Benjamin Gooden, Matthew C Lyons, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 19, 2007
Validity of Hamilton Depression Inventory in Parkinson's diseaseNadeeka N W Dissanayaka, Anna Sellbach, Sally Matheson, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 2, 2009
Haplotype analysis of the PARK 11 gene, GIGYF2, in sporadic Parkinson's diseaseGreg T Sutherland, Gerhard A Siebert, Jeremy R B Newman, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 13, 2010
Anxiety disorders in Parkinson's disease: prevalence and risk factorsNadeeka N W Dissanayaka, Anna Sellbach, Sally Matheson, et al.
Psychological Medicine|September 1, 2016
Anticholinergic burden in schizophrenia and ability to benefit from psychosocial treatment programmes: a 3-year prospective cohort studyK O'Reilly, P O'Connell, G Donohoe, et al.
Pageof 32